Artal Group’s Acceleron Pharma XLRN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-1,000,000	Closed	-$172M	–	167
2021 Q3	$172M	Sell	1,000,000 -400,000	-29%	-$52.3M	4.23%	6
2021 Q2	$176M	Hold	1,400,000	–	–	4%	6
2021 Q1	$190M	Hold	1,400,000	–	–	4.02%	7
2020 Q4	$179M	Hold	1,400,000	–	–	4.1%	5
2020 Q3	$158M	Hold	1,400,000	–	–	5.2%	5
2020 Q2	$133M	Sell	1,400,000 -100,000	-7%	-$9.64M	4.54%	5
2020 Q1	$135M	Buy	1,500,000 +300,000	+25%	+$23.3M	6.45%	2
2019 Q4	$63.6M	Sell	1,200,000 -300,000	-20%	-$13.7M	2.65%	10
2019 Q3	$59.3M	Hold	1,500,000	–	–	2.88%	11
2019 Q2	$61.6M	Sell	1,500,000 -150,000	-9%	-$6.21M	2.83%	10
2019 Q1	$76.8M	Buy	1,650,000 +600,000	+57%	+$26.3M	3.67%	5
2018 Q4	$45.7M	Buy	1,050,000 +50,000	+5%	+$2.5M	2.28%	13
2018 Q3	$57.2M	Hold	1,000,000	–	–	1.99%	12
2018 Q2	$48.5M	Buy	1,000,000 +150,000	+18%	+$5.47M	1.27%	13
2018 Q1	$33.2M	Buy	850,000 +100,000	+13%	+$4.25M	0.49%	24
2017 Q4	$31.8M	Buy	750,000 +50,000	+7%	+$1.88M	0.59%	18
2017 Q3	$26.1M	Hold	700,000	–	–	0.52%	14
2017 Q2	$21.3M	Sell	700,000 -50,000	-7%	-$1.45M	0.47%	25
2017 Q1	$19.9M	Buy	750,000 +600,000	+400%	+$15.8M	0.51%	21
2016 Q4	$3.83M	Sell	150,000 -25,000	-14%	-$792K	0.1%	60
2016 Q3	$6.33M	Buy	175,000 +75,000	+75%	+$2.48M	0.16%	48
2016 Q2	$3.4M	Buy	+100,000	New	+$3.25M	0.08%	51